EverlyWell believes consumers deserve access to affordable lab tests and insightful, digitally-enabled results with actionable next steps. The company connects consumers to lab partners offering a suite of validated lab tests including Food Sensitivity, Fertility and Women's Hormones, STDs, and Thyroid. Prices are straightforward starting at $49 and are generally covered by Flexible Spending and Health Savings Accounts. Physician-reviewed, actionable test results from CLIA-certified labs are provided within days of sample receipt.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
04/16/19 | $50,000,000 | Venture |
Goodwater Capital Highland Capital Partners Next Coast Ventures NextGen Venture Partners SoGal Ventures | undisclosed |
12/03/20 | $175,000,000 | Series D |
BlackRock Foresite Capital Goodwater Capital Highland Capital Partners Lux Capital Morningside Venture Next Coast Ventures Portfolia The Chernin Group | undisclosed |